Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Gas Gangrene | 2 | 2017 | 8 | 1.44 | Why? |
| Hypothermia, Induced | 3 | 2018 | 176 | 1.26 | Why? |
| Heat Stroke | 3 | 2018 | 22 | 1.08 | Why? |
| Antivenins | 3 | 2018 | 41 | 1.03 | Why? |
| Spiders | 2 | 2018 | 6 | 0.91 | Why? |
| Antitoxins | 2 | 2017 | 10 | 0.91 | Why? |
| Brain Injuries, Traumatic | 2 | 2017 | 381 | 0.90 | Why? |
| Clostridium perfringens | 1 | 2017 | 8 | 0.73 | Why? |
| Venoms | 1 | 2017 | 24 | 0.71 | Why? |
| Spider Bites | 1 | 2017 | 4 | 0.70 | Why? |
| Botulism | 1 | 2017 | 18 | 0.69 | Why? |
| Thrombomodulin | 1 | 2017 | 121 | 0.67 | Why? |
| Tetanus | 1 | 2017 | 61 | 0.65 | Why? |
| Snake Bites | 1 | 2017 | 50 | 0.65 | Why? |
| Diphtheria | 1 | 2017 | 74 | 0.64 | Why? |
| Abbreviated Injury Scale | 1 | 2015 | 22 | 0.63 | Why? |
| Neuroleptic Malignant Syndrome | 3 | 2020 | 41 | 0.61 | Why? |
| Disseminated Intravascular Coagulation | 3 | 2019 | 994 | 0.57 | Why? |
| Sepsis | 7 | 2020 | 3517 | 0.55 | Why? |
| Immune Sera | 1 | 2017 | 884 | 0.48 | Why? |
| Subarachnoid Hemorrhage | 4 | 2019 | 611 | 0.45 | Why? |
| Body Temperature | 2 | 2018 | 875 | 0.43 | Why? |
| Propofol | 2 | 2020 | 172 | 0.35 | Why? |
| Glasgow Outcome Scale | 2 | 2017 | 56 | 0.34 | Why? |
| Blood Coagulation Disorders | 2 | 2018 | 2040 | 0.33 | Why? |
| Hypnotics and Sedatives | 4 | 2020 | 624 | 0.32 | Why? |
| Horses | 2 | 2017 | 474 | 0.30 | Why? |
| Critical Illness | 4 | 2021 | 17281 | 0.23 | Why? |
| Glasgow Coma Scale | 2 | 2019 | 249 | 0.23 | Why? |
| Antipsychotic Agents | 2 | 2020 | 887 | 0.22 | Why? |
| Serotonin Syndrome | 1 | 2020 | 26 | 0.21 | Why? |
| Immunization, Passive | 1 | 2017 | 10067 | 0.21 | Why? |
| Lactates | 2 | 2017 | 59 | 0.21 | Why? |
| Registries | 3 | 2019 | 12327 | 0.19 | Why? |
| Heat Exhaustion | 1 | 2018 | 9 | 0.19 | Why? |
| Hyperoxia | 1 | 2019 | 51 | 0.19 | Why? |
| Benzamidines | 1 | 2020 | 206 | 0.19 | Why? |
| Critical Care | 7 | 2020 | 14081 | 0.19 | Why? |
| Spider Venoms | 1 | 2018 | 2 | 0.19 | Why? |
| Japan | 10 | 2020 | 6653 | 0.19 | Why? |
| Laryngeal Masks | 1 | 2019 | 68 | 0.19 | Why? |
| Out-of-Hospital Cardiac Arrest | 2 | 2019 | 1047 | 0.19 | Why? |
| Cryotherapy | 1 | 2018 | 31 | 0.19 | Why? |
| Advanced Trauma Life Support Care | 1 | 2017 | 2 | 0.18 | Why? |
| Colubridae | 1 | 2017 | 6 | 0.18 | Why? |
| Snake Venoms | 1 | 2017 | 29 | 0.18 | Why? |
| Aneurysm | 1 | 2019 | 117 | 0.18 | Why? |
| Adrenergic alpha-2 Receptor Agonists | 1 | 2017 | 47 | 0.17 | Why? |
| Disease Management | 1 | 2015 | 6841 | 0.17 | Why? |
| Blood Coagulation | 3 | 2019 | 2768 | 0.16 | Why? |
| Vena Cava, Inferior | 1 | 2017 | 103 | 0.16 | Why? |
| Hospital Mortality | 7 | 2019 | 22087 | 0.16 | Why? |
| Life Support Care | 1 | 2017 | 161 | 0.16 | Why? |
| Bacterial Toxins | 1 | 2017 | 185 | 0.16 | Why? |
| Partial Thromboplastin Time | 1 | 2017 | 436 | 0.15 | Why? |
| Guanidines | 1 | 2020 | 499 | 0.15 | Why? |
| Dexmedetomidine | 1 | 2017 | 130 | 0.15 | Why? |
| Wounds and Injuries | 2 | 2020 | 1708 | 0.15 | Why? |
| Antigens | 1 | 2017 | 267 | 0.15 | Why? |
| Sodium | 1 | 2017 | 309 | 0.15 | Why? |
| HMGB1 Protein | 1 | 2017 | 223 | 0.15 | Why? |
| Wounds, Nonpenetrating | 1 | 2017 | 157 | 0.15 | Why? |
| Intensive Care Units | 8 | 2021 | 29594 | 0.14 | Why? |
| Hemolysis | 1 | 2017 | 283 | 0.14 | Why? |
| Rats, Sprague-Dawley | 1 | 2017 | 987 | 0.14 | Why? |
| Antithrombins | 1 | 2018 | 353 | 0.14 | Why? |
| Hot Temperature | 2 | 2018 | 1299 | 0.13 | Why? |
| Emergency Medical Services | 2 | 2020 | 3557 | 0.12 | Why? |
| Organ Dysfunction Scores | 1 | 2019 | 1475 | 0.12 | Why? |
| Blood Coagulation Tests | 1 | 2017 | 855 | 0.12 | Why? |
| Intracranial Aneurysm | 1 | 2017 | 504 | 0.12 | Why? |
| Decision Support Techniques | 1 | 2019 | 903 | 0.11 | Why? |
| Prospective Studies | 9 | 2019 | 43301 | 0.11 | Why? |
| Platelet Count | 1 | 2017 | 1381 | 0.11 | Why? |
| Brain | 2 | 2019 | 5133 | 0.11 | Why? |
| Recovery of Function | 2 | 2019 | 2461 | 0.10 | Why? |
| Personnel Staffing and Scheduling | 1 | 2019 | 1578 | 0.10 | Why? |
| Airway Management | 1 | 2019 | 1298 | 0.10 | Why? |
| Pyrazines | 1 | 2020 | 1783 | 0.10 | Why? |
| Aged | 19 | 2021 | 215776 | 0.10 | Why? |
| Heart Rate | 1 | 2018 | 1527 | 0.09 | Why? |
| Shock, Septic | 1 | 2019 | 1313 | 0.09 | Why? |
| Amides | 1 | 2020 | 1864 | 0.09 | Why? |
| Immunization | 1 | 2017 | 2019 | 0.09 | Why? |
| Emergency Medicine | 1 | 2018 | 936 | 0.09 | Why? |
| Male | 22 | 2021 | 367725 | 0.09 | Why? |
| Fibrin Fibrinogen Degradation Products | 3 | 2021 | 5993 | 0.09 | Why? |
| Blood Transfusion | 1 | 2017 | 1399 | 0.09 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.09 | Why? |
| Health Status | 2 | 2018 | 3259 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.08 | Why? |
| Heart Arrest | 1 | 2017 | 1239 | 0.08 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2019 | 1876 | 0.08 | Why? |
| Female | 21 | 2021 | 380317 | 0.08 | Why? |
| Animals | 5 | 2018 | 78931 | 0.08 | Why? |
| Humans | 32 | 2021 | 930598 | 0.07 | Why? |
| Cognitive Dysfunction | 1 | 2017 | 1389 | 0.07 | Why? |
| Multivariate Analysis | 3 | 2019 | 5440 | 0.06 | Why? |
| Nervous System Diseases | 2 | 2018 | 4092 | 0.06 | Why? |
| Adrenergic Agonists | 1 | 2019 | 4 | 0.05 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.05 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.05 | Why? |
| Prognosis | 3 | 2019 | 32490 | 0.05 | Why? |
| Adult | 10 | 2021 | 244371 | 0.05 | Why? |
| Logistic Models | 3 | 2020 | 9089 | 0.05 | Why? |
| Rewarming | 1 | 2018 | 11 | 0.05 | Why? |
| Lethal Dose 50 | 1 | 2018 | 63 | 0.05 | Why? |
| Tokyo | 1 | 2021 | 645 | 0.05 | Why? |
| Conscious Sedation | 1 | 2020 | 222 | 0.04 | Why? |
| Anticoagulants | 1 | 2019 | 9563 | 0.04 | Why? |
| Treatment Outcome | 6 | 2019 | 51732 | 0.04 | Why? |
| Oral Medicine | 1 | 2018 | 51 | 0.04 | Why? |
| Extracellular Matrix Proteins | 1 | 2017 | 95 | 0.04 | Why? |
| Epinephrine | 1 | 2019 | 323 | 0.04 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.04 | Why? |
| Whole Body Imaging | 1 | 2017 | 116 | 0.04 | Why? |
| Matrix Metalloproteinases | 1 | 2017 | 131 | 0.04 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.04 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2020 | 669 | 0.04 | Why? |
| Hypernatremia | 1 | 2017 | 182 | 0.04 | Why? |
| Thermography | 1 | 2017 | 97 | 0.04 | Why? |
| Blood Coagulation Factors | 1 | 2017 | 223 | 0.04 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.04 | Why? |
| Time Factors | 4 | 2019 | 31397 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Neurologic Examination | 1 | 2017 | 428 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2019 | 14232 | 0.03 | Why? |
| Blood Gas Analysis | 1 | 2017 | 893 | 0.03 | Why? |
| Disability Evaluation | 1 | 2017 | 671 | 0.03 | Why? |
| Epidemiologic Methods | 1 | 2017 | 392 | 0.03 | Why? |
| Hyponatremia | 1 | 2017 | 371 | 0.03 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.03 | Why? |
| Syndrome | 1 | 2018 | 1310 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.03 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.03 | Why? |
| Fibrinogen | 1 | 2017 | 1048 | 0.03 | Why? |
| Adolescent | 3 | 2018 | 86841 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Leukocyte Count | 1 | 2021 | 3178 | 0.03 | Why? |
| Research Design | 2 | 2017 | 5830 | 0.03 | Why? |
| Methylprednisolone | 1 | 2021 | 2107 | 0.03 | Why? |
| Cognition | 1 | 2018 | 1394 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Equipment Design | 1 | 2019 | 3095 | 0.02 | Why? |
| Physical Therapy Modalities | 1 | 2017 | 1090 | 0.02 | Why? |
| Delirium | 1 | 2018 | 1061 | 0.02 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.02 | Why? |
| Neurology | 1 | 2019 | 1613 | 0.02 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.02 | Why? |
| Risk | 1 | 2019 | 5288 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Survivors | 1 | 2018 | 2619 | 0.02 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.02 | Why? |
| Oxygen | 1 | 2019 | 3715 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.02 | Why? |
| Patient Selection | 1 | 2019 | 4560 | 0.02 | Why? |
| Young Adult | 1 | 2015 | 93724 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.02 | Why? |
| Neutralization Tests | 1 | 2018 | 6698 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 5002 | 0.01 | Why? |
| Brain Ischemia | 1 | 2017 | 2813 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2019 | 8248 | 0.01 | Why? |
| Patient Discharge | 1 | 2017 | 5696 | 0.01 | Why? |
| Mental Health | 2 | 2018 | 15770 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2019 | 48226 | 0.01 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.01 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
Hifumi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(179)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_